Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Inhibrx Biosciences, Inc
Inhibrx Biosciences, Inc
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
City of Hope Medical Center
Columbia University
Pfizer
Gradalis, Inc.
Gradalis, Inc.
University of California, San Francisco
National Cancer Institute (NCI)
University of Florida
NYU Langone Health
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Institutes of Health Clinical Center (CC)
University of Washington